The HIH especially supports the academic goals of its female scientists. Here you will find the Tübingen Support Programme for Women (TÜFF) offered by the Faculty of Medicine at the Tübingen…
Phase I of the clinical trial in the fight against glioblastoma, one of the most aggressive solid tumors, starts today at the University Hospital of Tübingen. This tumor occurs in the central nervous…
At the HIH, as part of the Johannes Dichgans scholarship program, a doctoral scholarship for students of human medicine will again be offered for the winter semester 2021/22.
The HIH sees the…
The department of Neurology & Stroke (Clinical Director: Prof. Dr. Ulf Ziemann) covers a broad variety of neurological disorders.
Patients are referred locally, supra-regionally and…
Excellent postdoctoral fellow in Neuro-Oncology (f/m/d) The Hertie Institute for Clinical Brain Research (HIH), together with the University of Tübingen’s Neurology Hospital, forms the Center of…
The blood concentration of the neural protein neurofilament light chain (NfL) may be related to the life expectancy in very old people, reports an international team headed by Prof. Mathias Jucker.…